Valuation (47%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 347.26 | 95.09 |
| PEG Ratio (TTM) | -3.55 | -1.70 |
| P/S Ratio (TTM) | 1.82 | 1.30 |
| P/B Ratio (TTM) | 1.88 | 1.91 |
| P/FCF Ratio (TTM) | -58.45 | -1.21 |
| Price to 5YR AVG Earnings Ratio | 2.10 | 22.82 |
| Price to 5YR AVG FCF Ratio | 2.23 | 8.48 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.14% | 2.82% |
| ROE (TTM) | 0.51% | 5.04% |
| Net Profit Margin (TTM) | 0.55% | 1.62% |
| ROIC 5YR AVG | 13.34% | 19.78% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -331.27% | -306.71% | -156.65% |
| Revenue | 6.58% | 48.36% | 29.30% |
| Net Income | -336.28% | -360.21% | -189.87% |
| Cash Flow | 22.96% | 51.38% | 31.41% |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.48 | 2.68 |
| Quick Ratio (TTM) | 2.02 | 1.82 |
| D/E Ratio (TTM) | 2.17 | 1.03 |
| Interest Coverage (TTM) | 2.80 | 11.32 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 0.50 | 3.25 |
| LTL to 5YR AVG FCF | 12.51 | 6.90 |
| Shares Outstanding Growth 5YR AVG | 3.87% | 2.06% |